Skip to main content
Clinical Trials/CTRI/2019/05/019103
CTRI/2019/05/019103
Recruiting
未知

A randomised controlled trial to compare the efficacy of Apremilast and Doxycycline in patients of moderate hidradenitis suppurativa.

Post Graduate institute of medical education and research0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Post Graduate institute of medical education and research
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Post Graduate institute of medical education and research

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients diagnosed as HS based on the San Francisco modification of Dessau criteria and severity defined as moderate (stage II) by Hurley staging and HS\-PGA score more than 3\.
  • 2\.Age \> 18 years.
  • 3\.Patients who can give valid consent.
  • 4\.Willing for monthly follow\-up visits for at least 3 months.

Exclusion Criteria

  • 1\.Pregnant and lactating mothers
  • 2\.Severe hepatic/renal dysfunction
  • 3\.Patients with HIV, Hepatitis B and Hepatitis C
  • 4\.Inability to come for monthly follow up visits for 3 months
  • 5\.Those who cannot provide consent for the study
  • 6\.Known case of psychiatric disease

Outcomes

Primary Outcomes

Not specified

Similar Trials